Perioperative medicine & outcomes

Perioperative Penicillin and Cephalosporin Antibiotic Allergy Assessment and Testing: The PREPARE Pilot Randomized Clinical Trial

JAMA SurgPublished Randomised controlled trial

Authors' conclusion

Low-risk β-lactam AAL were successfully evaluated and delabeled by anesthesiologists in the preoperative clinic using the intervention.

Study context

Population
Adults with a reported β-lactam antibiotic allergy label likely to require IV perioperative antibiotic prophylaxis, preoperative anesthesiologist-led clinics at 3 tertiary hospitals in Melbourne, Australiaof 511 eligible
Participants
150 adults
Comparison
Intervention vs Control
  • Interventionn = 74
  • Controln = 76reference
Primary endpoint
Feasibility: proportion randomised to intervention receiving it per protocol and proportion of eligible patients consenting; safety: proportion of intervention group with antibiotic-associated AE
Follow-up
Within 90 days postsurgery (safety)
Methodological detailsmulticentre, phase 2 feasibility and safety trial, 1:1 randomisation
  • Multicentre
  • Phase 2 feasibility and safety trial
  • 1:1 randomisation

Primary result

As reported in the abstract

Feasibility of recruitment and intervention delivery

Enrolled of eligible patients: 150 of 511

29.4%

95% CI 25.4%–33.5%

Intervention patients who had allergy testing: 47 of 74

63.5%

95% CI 51.5%–74.4%

Low-risk patients proceeding to allergy testing: 28 of 30

93%

Moderate/high-risk patients proceeding to allergy testing: 19 of 44

43%

Further findings

Restricted antibiotic use

Safety

OutcomeIntervention
Antibiotic-related AE (primary safety outcome) · within 90 days postsurgery5.4% (95% CI 1.5%–13.3%)
Antibiotic-related adverse event (AE) (primary safety outcome) — Immune-mediated events (benign rash), without delay to surgery
1

Original publication

Perioperative Penicillin and Cephalosporin Antibiotic Allergy Assessment and Testing: The PREPARE Pilot Randomized Clinical Trial. JAMA Surg. Published 1 May 2025. doi:10.1001/jamasurg.2025.0279

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.